Page last updated: 2024-08-23

paclitaxel and Pseudomyxoma Peritonei

paclitaxel has been researched along with Pseudomyxoma Peritonei in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Arjona-Sanchez, A; Aziz, O; Briceño, J; Casado-Adam, A; Esquivel, J; Glehen, O; Nedelcut, DS; Passot, G; Piso, P; Rodriguez-Ortiz, L; Rufian-Peña, S; Salti, G; Sanchez-Hidalgo, JM; Selvasekar, CR; Sommariva, A; Turaga, K; Van der Speeten, K; Yonemura, Y1
Keating, JP; Kenwright, DN; Saluja, M1
Arjona-Sánchez, Á; Casado-Adam, Á; Díaz-Nieto, R; Muñoz-Casares, FC; Ortega-Salas, R; Rubio-Pérez, MJ; Rufián-Peña, S1
Fujitani, K; Hirao, M; Ikenaga, M; Kashiwazaki, M; Manoh, M; Mishima, H; Miyazaki, M; Nakamori, S; Ogawa, H; Takeda, M; Tsujinaka, T; Yasui, M1

Reviews

1 review(s) available for paclitaxel and Pseudomyxoma Peritonei

ArticleYear
Pseudomyxoma Peritonei arising from a mucinous borderline ovarian tumour: Case report and literature review.
    The Australian & New Zealand journal of obstetrics & gynaecology, 2010, Volume: 50, Issue:4

    Topics: Antineoplastic Agents; Appendix; Carboplatin; Chemotherapy, Adjuvant; Cystadenocarcinoma, Mucinous; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Pseudomyxoma Peritonei

2010

Other Studies

3 other study(ies) available for paclitaxel and Pseudomyxoma Peritonei

ArticleYear
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2021, Volume: 47, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Cytoreduction Surgical Procedures; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Hyperthermic Intraperitoneal Chemotherapy; Laparoscopy; Length of Stay; Male; Mesothelioma; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm, Residual; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Peritoneal Neoplasms; Pseudomyxoma Peritonei; Registries; Severity of Illness Index; Survival Rate; Tumor Burden

2021
Pseudomyxoma peritonei treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: results from a single centre.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2011, Volume: 13, Issue:4

    Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Humans; Hyperthermia, Induced; Mitomycin; Paclitaxel; Peritoneal Neoplasms; Pseudomyxoma Peritonei

2011
[A case report of pseudomyxoma peritonei demonstrating complete response after intensive therapy consisting of cytoreductive surgery and adjuvant chemotherapy with paclitaxel and S-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Humans; Male; Oxonic Acid; Paclitaxel; Pseudomyxoma Peritonei; Tegafur; Tomography, X-Ray Computed

2008